Advertisement
Journal Home
Search for

Volume 200, Issue 4, Pages 412.e1-412.e10 (April 2009)


View previous. 25 of 54 View next.

Articles in fullDrug use and limited prenatal care: an examination of responsible barriers

Ashley H. Schempf, PhDCorresponding Author Informationemail address, Donna M. Strobino, PhD

Received 27 March 2008; received in revised form 6 July 2008; accepted 30 October 2008. published online 17 February 2009.

Objective

The purpose of this study was to determine sociodemographic, psychosocial, and health belief factors that explain the association between maternal drug use and little or no prenatal care.

Study Design

A cohort of 812 low-income women who delivered at Johns Hopkins Hospital were administered a postpartum survey. Drug use was determined by self-report, medical record, and toxicologic screens. Medical records were abstracted to determine little or no prenatal care, as defined by ≤ 1 visit.

Results

Adjustments for sociodemographic characteristics and cocaine and opiate use were predictive of little or no prenatal care. The effect of cocaine was explained by psychosocial and health belief factors: external locus of control, fear of being reported to police, and disbelief in the efficacy of care. Opiate use remained strongly related to little or no care in fully adjusted models (odds ratio, 3.16; P < .001).

Conclusion

Different outreach and education strategies may be necessary to enroll cocaine- vs opiate-using women into prenatal care.

Department of Population, Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD

Corresponding Author InformationReprints: Ashley H. Schempf, PhD, Department of Population, Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD 21205

 Cite this article as: Schempf AH, Strobino DM. Drug use and limited prenatal care: an examination of responsible barriers. Am J Obstet Gynecol 2009;200:412.e1-412.e10.

 This study was supported by Grants from the National Institutes of Health: NIDA R01-DA007621 (D.M.S.) and NIDA R03-DA020632 (A.H.S.).

 Authorship and contribution to the article is limited to the 2 authors indicated.

PII: S0002-9378(08)02198-4

doi:10.1016/j.ajog.2008.10.055


View previous. 25 of 54 View next.

Advertisement